RecruitingNot ApplicableNCT06088953

EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER

DEAFNESS SCREENING IN A MEMORY CENTER IN SUBJECTS WITH COGNITIVE DISORDERS


Sponsor

University Hospital, Lille

Enrollment

200 participants

Start Date

May 27, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Age-related hearing loss (ARHL), like neurodegenerative diseases, appears insidiously with age. As major public health issues, they are nonetheless under-diagnosed because the presence of one can hinder the objectification of the other. The CogAudio project aims to detect early and in an ambulatory mode in a memory centre a speech perception disorder in noise thanks to the VRB test in patients weakened by cognitive disorders.


Eligibility

Min Age: 50 Years

Inclusion Criteria6

  • Patient with mild to moderate cognitive impairment, with an MMSE score ≥15/30
  • Patient mastering the French language
  • Patient who has given written consent to participate in the trial
  • Socially insured patient
  • Patient willing to comply with all study procedures and duration
  • Patient accompanied by a study partner

Exclusion Criteria6

  • Medical history of diagnosed deafness, fitted or not
  • History of progressive otological pathology or presence of tympanic obstruction (>1/3 of the surface of the eardrum)
  • History of unstabilized psychiatric pathology
  • Major visual impairment (Age-Related Macular Degeneration AMD...)
  • Established diagnosis of major language disorders (Primary Progressive Aphasia APP...)
  • Major under legal protection measure

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTVRB test

V1 (inclusion) : VRB test for detecting speech comprehension disorders in noise. V2 (3 months) : all patients ( independent of the result of the VRB test) will be invited to attend a hearing test within 3 months in order to confirm the diagnosis of deafness by means of a tone audiometry and an ENT medical consultation.


Locations(1)

Hôpital Roger Salengro

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06088953


Related Trials